Rockefeller University
Clinical trials sponsored by Rockefeller University, explained in plain language.
-
First human test for promising hepatitis b fighter
Disease control Recruiting nowThis is a first-step study to see if a new lab-made antibody is safe for people with chronic Hepatitis B. Thirty-seven participants already on standard medication will receive a single dose of the antibody or a placebo. Researchers will monitor for side effects and track how the …
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Researchers investigate why aspirin fails some moms at risk of dangerous pregnancy condition
Knowledge-focused Recruiting nowThis study aims to understand why low-dose aspirin, a common preventive treatment, sometimes fails to stop preeclampsia from recurring in high-risk pregnancies. Researchers will enroll 130 women with a history of preeclampsia who took aspirin in a later pregnancy. They will compa…
Phase: EARLY_PHASE1 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Scientists seek genetic clues to mysterious bleeding disorders
Knowledge-focused Recruiting nowThis research study aims to better understand inherited blood disorders like Glanzmann thrombasthenia, a condition that causes excessive bleeding. Researchers will analyze blood samples from patients and healthy volunteers to study how blood cells work and identify genetic causes…
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC